How a single imaging platform exposes the shifting dynamics of China’s surgical supply chain.

UX7 Series Endoscope Camera System (4K, NIR Fluorescence & 3D)

Hospital procurement teams evaluating endoscopic video systems have long faced a binary trade-off: choose Japanese or German optics for surgical precision, or accept domestic alternatives with lower resolution and fewer modalities. The UX7 Series, built by a Chinese manufacturer with full-chain independent R&D, complicates that calculus. It integrates true 4K imaging, near-infrared fluorescence, and real-time 3D visualization into a single platform — specifications that, until recently, were rare even in imports.

The system relies on dual-chip true 4K sensors and advanced image algorithms capable of delivering high dynamic range and even brightness across the surgical field. Its fluorescence mode detects near-infrared signals to visualize vascular structures and tissue perfusion in real time. Surgeons gain immediate feedback on blood supply and anatomical boundaries — information that directly reduces the risk of incomplete resection or ischemic complications during minimally invasive procedures.

The hardware reflects a deliberate engineering focus on intraoperative stability. Autofocus, automatic scene recognition, and chip-on-tip active heating defogging maintain image clarity even when a scope shifts between wet and dry tissue environments. The camera head weighs 190 grams in white-light mode and 240 grams with fluorescence sensors — light enough for extended use without arm fatigue, heavy enough to suggest robust cooling and optical assembly inside.

The UX7 is compatible with rigid endoscopes in 10 mm, 5 mm, and 3 mm diameters, with 0° and 30° viewing angles, and supports autoclave, low-temperature plasma, and ethylene oxide sterilization. That range — from prostate surgery to pediatric laparoscopy — allows a single system to move across specialties without reconfiguration. Recording is handled by a 4K medical digital video recorder with dual-channel simultaneous capture, and integration with PACS is built in, not bolted on.

From a procurement perspective, the UX7 signals a broader shift. Chinese manufacturers now control the full stack — sensors, optics, light sources, processing algorithms, and recording hardware — meaning fewer import dependencies and lower per-unit costs. For a regional hospital upgrading from 1080p to 4K, the all-in-one design eliminates the need to source monitors, light sources, and recorders from separate vendors. For a surgical team adopting fluorescence-guided procedures for the first time, there is no separate fluorescence module to buy or learn.

Domestic production of medical imaging systems in China has historically lagged in the high-end segment, particularly in sensor fabrication and optical coatings. The UX7’s dual-chip architecture and NIR fluorescence detection suggest that the domestic supply chain has matured enough to support advanced optoelectronic subsystems — a development that reshapes competition not just in China, but in price-sensitive markets across Southeast Asia, the Middle East, and Africa that have long relied on refurbished or second-tier surgical equipment.

What makes the UX7 worth watching is not its specification sheet — it is that the specification sheet exists at all in a product designed, manufactured, and supported entirely from within a Chinese industrial ecosystem that was, a decade ago, still trying to match the color reproduction of German endoscope cameras.

Why it matters:
For hospital procurement managers and surgical directors, the UX7 represents a rare convergence of multi-modal imaging, sterilization flexibility, and low integration risk. It reduces the number of suppliers involved in building a digital OR, simplifies training, and gives smaller institutions access to fluorescence guidance without the premium pricing typically attached to western systems.

View Product →